000286608 001__ 286608
000286608 005__ 20240419160101.0
000286608 0247_ $$2doi$$a10.1038/s41579-023-00998-9
000286608 0247_ $$2pmid$$apmid:38110694
000286608 0247_ $$2ISSN$$a1740-1526
000286608 0247_ $$2ISSN$$a1740-1534
000286608 0247_ $$2altmetric$$aaltmetric:157571904
000286608 037__ $$aDKFZ-2023-02820
000286608 041__ $$aEnglish
000286608 082__ $$a610
000286608 1001_ $$00000-0002-3458-5604$$aRatiner, Karina$$b0
000286608 245__ $$aUtilization of the microbiome in personalized medicine.
000286608 260__ $$aBasingstoke$$bNature Publ. Group$$c2024
000286608 3367_ $$2DRIVER$$aarticle
000286608 3367_ $$2DataCite$$aOutput Types/Journal article
000286608 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1713535236_19206$$xReview Article
000286608 3367_ $$2BibTeX$$aARTICLE
000286608 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000286608 3367_ $$00$$2EndNote$$aJournal Article
000286608 500__ $$a#LA:F220# / 2024 May;22(5):291-308
000286608 520__ $$aInter-individual human variability, driven by various genetic and environmental factors, complicates the ability to develop effective population-based early disease detection, treatment and prognostic assessment. The microbiome, consisting of diverse microorganism communities including viruses, bacteria, fungi and eukaryotes colonizing human body surfaces, has recently been identified as a contributor to inter-individual variation, through its person-specific signatures. As such, the microbiome may modulate disease manifestations, even among individuals with similar genetic disease susceptibility risks. Information stored within microbiomes may therefore enable early detection and prognostic assessment of disease in at-risk populations, whereas microbiome modulation may constitute an effective and safe treatment tailored to the individual. In this Review, we explore recent advances in the application of microbiome data in precision medicine across a growing number of human diseases. We also discuss the challenges, limitations and prospects of analysing microbiome data for personalized patient care.
000286608 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000286608 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000286608 7001_ $$aCiocan, Dragos$$b1
000286608 7001_ $$00009-0008-6787-1069$$aAbdeen, Suhaib K$$b2
000286608 7001_ $$0P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c$$aElinav, Eran$$b3$$eLast author$$udkfz
000286608 773__ $$0PERI:(DE-600)2121463-3$$a10.1038/s41579-023-00998-9$$n5$$p291-308$$tNature reviews / Microbiology$$v22$$x1740-1526$$y2024
000286608 909CO $$ooai:inrepo02.dkfz.de:286608$$pVDB
000286608 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000286608 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000286608 9141_ $$y2023
000286608 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-25$$wger
000286608 915__ $$0StatID:(DE-HGF)3003$$2StatID$$aDEAL Nature$$d2023-10-25$$wger
000286608 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNAT REV MICROBIOL : 2022$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-25
000286608 915__ $$0StatID:(DE-HGF)9980$$2StatID$$aIF >= 80$$bNAT REV MICROBIOL : 2022$$d2023-10-25
000286608 9202_ $$0I:(DE-He78)F220-20160331$$kF220$$lMikrobiom und Krebs$$x0
000286608 9201_ $$0I:(DE-He78)F220-20160331$$kF220$$lMikrobiom und Krebs$$x0
000286608 9201_ $$0I:(DE-He78)D480-20160331$$kD480$$lMikrobiom und Krebs$$x1
000286608 980__ $$ajournal
000286608 980__ $$aVDB
000286608 980__ $$aI:(DE-He78)F220-20160331
000286608 980__ $$aI:(DE-He78)D480-20160331
000286608 980__ $$aUNRESTRICTED